Evidia | AI Transformation Index
Evidia is a structurally durable business — physical imaging infrastructure, European regulatory complexity, and capital intensity create genuine moats aga...
Overview
Evidia is a pan-European radiology and radiotherapy platform operating over 100 outpatient imaging and treatment centers across Germany and Scandinavia, generating fee-for-service revenue by providing MRI, CT, X-ray, nuclear medicine, and radiation therapy to patients via direct outpatient access and hospital cooperation agreements.
Executive Summary
Evidia is a structurally durable business — physical imaging infrastructure, European regulatory complexity, and capital intensity create genuine moats against AI-native disruption — but it sits on a meaningful unrealized AI opportunity concentrated in diagnostic interpretation throughput and report generation automation. The radiologist shortage across Germany and Scandinavia makes AI-assisted reading not just an efficiency play but a strategic imperative that could transform the staffing model and scan capacity. With a basic IT team and no visible AI roadmap, Evidia is a classic case where PE-sponsored AI transformation could create substantial value — but the sponsor should also track whether AI commoditizes the interpretation premium faster than operational gains can be captured.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
66.5
Ciridae AI Score
Durability Rationale
Evidia's durability rests primarily on the irreducible physicality of its service — patients must attend a facility to receive an MRI or radiation therapy, and the capital equipment required to deliver these outcomes cannot be replicated by software alone. Layered on top of this is a dense regulatory framework across Germany and Scandinavia governing facility licensing, radiation safety, and healthcare reimbursement that makes AI-native market entry structurally implausible. The principal durability risk is at the interpretation margin: as AI commoditizes the reading and reporting function, the value premium currently captured by radiologist interpretation could compress or migrate toward AI software vendors, and teleradiology platforms could erode Evidia's ability to charge for the cognitive layer of its service even while the physical scan revenue holds.
Opportunity Rationale
The most compelling AI opportunity for Evidia is the combination of high-magnitude improvement in the diagnostic interpretation workflow — where AI is already demonstrably effective in radiology — and meaningful domain intelligence that exists for AI compute to amplify at scale. The radiologist shortage across Europe creates a structural tension that AI-assisted reading directly resolves: the same number of radiologists can process substantially more scans, turning a staffing constraint into a throughput advantage. Evidia's limited internal AI sophistication (basic IT team, no evident AI roadmap) means the unrealized step-change is large and would require external catalysis — exactly the PE-relevant opportunity profile where an outside sponsor driving AI transformation creates step-change value the company cannot generate organically.
Key Risks
AI diagnostic software vendors (Aidoc, Enlitic, or large imaging OEMs like Siemens Healthineers building AI into scanner software) could capture the interpretation value margin directly, commoditizing Evidia's reading function and compressing per-scan economics faster than operational AI gains offset the loss.
Evidia's basic IT infrastructure and minimal engineering capability may mean the company cannot implement AI-assisted reading workflows without significant integration investment — and regulatory approval timelines for AI diagnostic tools in Germany and Scandinavia could delay capture of the opportunity well beyond the PE hold period.
Company Overview
| Headquarters | Germany and Scandinavia (no specific city mentioned, but the company operates extensively in these regions). [Evidia - EQT Group Portfolio](https://eqtgroup.com/about/current-portfolio/evidia) |
| Products / Services | Radiological services including MRI, CT, X-ray, ultrasound, mammography, bone density measurement, nuclear medical treatments, and radiotherapy treatments. [Evidia - EQT Group Portfolio](https://eqtgroup.com/about/current-portfolio/evidia) |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Evidia Acquisition of 4ways (Teleradiology Services Provider) April 5, 2023 | Evidia acquired 4ways, a leading UK and European tele-diagnostic and teleradiology services provider. This acquisition expanded Evidia's teleradiology capabilities and presence in the UK market. 4ways was previously owned by growth-focused private equity investor ECI Partners, who fully realized their investment through this sale. The acquisition supports Evidia's strategy to enhance its technology platform and clinical expertise across Europe. [Evidia Group](https://evidiagroup.com/news/latest-news/evidia-aquires-4ways) |
EQT Infrastructure V Acquisition of Majority Stake in Evidia December 2021 | EQT Infrastructure V, managed by EQT Partners AB, completed the acquisition of an unknown majority stake in evidia GmbH from DBAG Fund VII, managed by Deutsche Beteiligungs AG. This transaction marked EQT's entry as the controlling private equity investor in Evidia. The acquisition was part of EQT Infrastructure V's strategy to invest in social infrastructure and healthcare sectors. Evidia is a leading radiology and radiotherapy platform in Europe, operating mainly in Germany and Scandinavia. [Evidia - EQT Group Portfolio](https://eqtgroup.com/about/current-portfolio/evidia), [Marketscreener](https://www.marketscreener.com/quote/stock/DEUTSCHE-BETEILIGUNGS-AG-13507223/news/EQT-Infrastructure-V-managed-by-EQT-Partners-AB-completed-the-acquisition-of-an-unknown-majority-st-41797605), [Evidia Group](https://evidiagroup.com/management/board-of-directors-evidia-group), [Evidia - EQT Group Portfolio](https://eqtgroup.com/about/current-portfolio/evidia) |
Executives
| Name | Background |
|---|---|
Liselott Kilaas Group CEO | Liselott Kilaas is the Group CEO of Evidia. She has extensive leadership experience, previously serving as Group CEO at Avonova Group for over 3 years. She has also held various board roles, including at IMD Business School and Recover Nordic Group. Liselott holds an MBA from IMD Business School and is based in Oslo, Norway. Her broad experience spans healthcare and business leadership, positioning her well to lead Evidia's growth and strategic direction [LinkedIn](https://linkedin.com/in/liselottkilaas). |
Niels Ackermann Chief Financial Officer | Niels Ackermann serves as the CFO of Evidia Group. He has a strong background in strategic corporate management and finance, with prior experience as CFO in a private equity portfolio company. His expertise includes finance, controlling, and driving competitiveness in healthcare businesses. Niels is committed to supporting Evidia's growth as a preferred radiology brand in Europe [Evidia News](https://evidiagroup.com/news/latest-news/enhancement-of-management-team). |
Zisis Sotiriou Chief Operating Officer | Zisis Sotiriou is the COO of Evidia Group. He is an experienced technology expert with deep knowledge in radiology. Previously, he was Senior Vice-President and Regional COO at Affidea Group, where he demonstrated technical expertise and innovation leadership. At Evidia, he focuses on product development, operational efficiency, security, strategic partnerships, and AI technology integration [Evidia News](https://evidiagroup.com/news/latest-news/enhancement-of-management-team). |
Alexander Jenner Chief Strategy Officer | Alexander Jenner is the Chief Strategy Officer at Evidia Group. He has a strong background in healthcare investment banking, having worked at Morgan Stanley as Executive Director in German Healthcare Investment Banking and at Greenhill & Co. in various roles. He is based in Frankfurt, Germany, and educated at HHL Leipzig Graduate School of Management [LinkedIn](https://linkedin.com/in/alexander-jenner-a4370b44). |
Selma Heinrich CEO Evidia Germany | Selma Heinrich leads Evidia Germany as CEO. She brings long-term experience from the healthcare sector and the Innovation Hub of the Federal Ministry of Health. With a business administration background and industry knowledge, she focuses on employee potential and innovative treatment methods [Evidia News](https://evidiagroup.com/news/latest-news/enhancement-of-management-team). |
Florian Grigull Chief Human Resources Officer | Florian Grigull is CHRO at Evidia Germany with over 1.5 years in the role. Previously, he worked at Fresenius Medical Care as Head of HR for the German market for nearly 12 years. He is based in Gemünden, Bavaria, Germany [LinkedIn](https://linkedin.com/in/florian-grigull-196b91128). |

EQT